Applied Topically News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Applied Topically. Real-time updates on events, politics, business and more.

FDA Announces Approval of Roflumilast Foam for Seborrheic Dermatitis

December 16, 2023

The approval of the once-daily, steroid free foam marks the first approval of a drug by the FDA for the skin condition.

Source: hcplive.com

April 20, 2023

If approved, the once-daily foam would be the first topical drug with a new mechanism of action for seborrheic dermatitis in more than two decades.

Source: medscape.com

April 18, 2023

It was announced by Arcutis Biotherapeutics that the US Food and Drug Administration had accepted for review their NDA for roflumilast foam 0.3%.

Source: hcplive.com